[go: up one dir, main page]

NO954942L - Nye erytromycinderivater, fremgangsmåte for deres fremstilling og anvendelse av derivatene som legemidler - Google Patents

Nye erytromycinderivater, fremgangsmåte for deres fremstilling og anvendelse av derivatene som legemidler

Info

Publication number
NO954942L
NO954942L NO954942A NO954942A NO954942L NO 954942 L NO954942 L NO 954942L NO 954942 A NO954942 A NO 954942A NO 954942 A NO954942 A NO 954942A NO 954942 L NO954942 L NO 954942L
Authority
NO
Norway
Prior art keywords
derivatives
drugs
processes
preparation
new erythromycin
Prior art date
Application number
NO954942A
Other languages
English (en)
Other versions
NO308361B1 (no
NO954942D0 (no
Inventor
Constantin Agouridas
Yannick Benedetti
Jean-Francois Chantot
Alexis Denis
Odile Le Martret
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of NO954942D0 publication Critical patent/NO954942D0/no
Publication of NO954942L publication Critical patent/NO954942L/no
Publication of NO308361B1 publication Critical patent/NO308361B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO954942A 1994-04-08 1995-12-06 Nye erytromycinderivater, samt legemidler som inneholder slike NO308361B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
PCT/FR1995/000441 WO1995027720A1 (fr) 1994-04-08 1995-04-06 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (3)

Publication Number Publication Date
NO954942D0 NO954942D0 (no) 1995-12-06
NO954942L true NO954942L (no) 1996-02-07
NO308361B1 NO308361B1 (no) 2000-09-04

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954942A NO308361B1 (no) 1994-04-08 1995-12-06 Nye erytromycinderivater, samt legemidler som inneholder slike

Country Status (49)

Country Link
US (2) US5656607A (no)
EP (1) EP0676409B1 (no)
JP (1) JP3000023B2 (no)
KR (1) KR100317148B1 (no)
CN (1) CN1059445C (no)
AP (1) AP587A (no)
AT (1) ATE234853T1 (no)
AU (1) AU684939B2 (no)
BG (1) BG61916B1 (no)
BR (1) BR9506147A (no)
CA (1) CA2164638C (no)
CO (1) CO4370097A1 (no)
CZ (1) CZ296005B6 (no)
DE (1) DE69529934T2 (no)
DK (1) DK0676409T3 (no)
DZ (1) DZ1869A1 (no)
EE (1) EE04498B1 (no)
ES (1) ES2189820T3 (no)
FI (1) FI111264B (no)
FR (1) FR2718450B1 (no)
GB (1) GB2288174A (no)
GE (1) GEP19991836B (no)
HR (1) HRP950217B1 (no)
HU (1) HU215396B (no)
IL (1) IL112954A (no)
IS (1) IS1865B (no)
JO (1) JO1850B1 (no)
LV (1) LV11182B (no)
MA (1) MA23501A1 (no)
MD (1) MD663G2 (no)
MY (1) MY114672A (no)
NO (1) NO308361B1 (no)
NZ (1) NZ284498A (no)
OA (1) OA10200A (no)
PE (1) PE2896A1 (no)
PL (1) PL180837B1 (no)
PT (1) PT676409E (no)
RO (1) RO115634B1 (no)
RU (1) RU2141965C1 (no)
SA (1) SA97170757A (no)
SI (1) SI0676409T1 (no)
SK (1) SK284079B6 (no)
SV (1) SV1995000018A (no)
TN (1) TNSN95026A1 (no)
TW (1) TW316908B (no)
UA (1) UA44705C2 (no)
WO (1) WO1995027720A1 (no)
YU (1) YU49221B (no)
ZA (1) ZA952059B (no)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
AU710532B2 (en) * 1996-05-07 1999-09-23 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
BR9711661A (pt) * 1996-09-04 1999-08-24 Abbott Lab Composto composi-Æo farmac-utica e processos para controlar uma infec-Æo bacteriana em um mam¡fero e para preparar um composto
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO1998042720A1 (fr) * 1997-03-24 1998-10-01 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
US6162794A (en) * 1997-05-09 2000-12-19 Pfizer Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
PL337606A1 (en) * 1997-06-11 2000-08-28 Pfizer Prod Inc Derivatives of erythromycin 9-oxime
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
DE69926005T2 (de) 1998-09-22 2006-05-18 Pfizer Products Inc., Groton Carbamat- und carbazatketolidantibiotika
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
ES2273964T3 (es) 1998-12-10 2007-05-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
FR2789392B1 (fr) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
JP2002542197A (ja) 1999-04-16 2002-12-10 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ケトライド抗菌剤
NZ515027A (en) * 1999-04-16 2004-01-30 Kosan Biosciences Inc Erythromycin derivatives as antibiotics
OA11945A (en) * 1999-05-24 2006-04-13 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
EP1404693A2 (en) 2001-07-03 2004-04-07 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
CN105039464A (zh) 2002-07-01 2015-11-11 阿基昂生命科学公司,以生物技术资源部的名义经营 用于生产葡糖胺和n-乙酰氨基葡糖的方法和物质
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
WO2004096823A2 (en) * 2003-04-25 2004-11-11 Chiron Corporation Novel ketolide derivatives
US7332476B2 (en) * 2003-04-25 2008-02-19 Novartis Ag Pyridyl substituted ketolide antibiotics
CA2703475A1 (en) * 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
EP2358379B1 (en) * 2008-10-24 2015-12-16 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
KR101945324B1 (ko) 2010-05-20 2019-02-07 셈프라 파마슈티컬스, 인크. 매크로라이드들 및 케톨라이드들과 이의 중간체들을 제조하는 공정들
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
KR20140139083A (ko) 2012-03-27 2014-12-04 셈프라 파마슈티컬스, 인크. 마크롤라이드계 항생제를 투여하기 위한 비경구 제제
RU2015138796A (ru) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
JP6675973B2 (ja) 2013-03-15 2020-04-08 センプラ ファーマシューティカルズ,インコーポレイテッド マクロライド抗菌薬を調製するための集束的な方法
AU2014248014B2 (en) 2013-04-04 2018-11-08 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
EP3211997A4 (en) 2014-10-08 2018-10-24 President and Fellows of Harvard College 14-membered ketolides and methods of their preparation and use
EP3273969A4 (en) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
IS4309A (is) 1995-11-17
PL311871A1 (en) 1996-03-18
HUT73772A (en) 1996-09-30
CN1126997A (zh) 1996-07-17
YU21695A (sh) 1997-12-05
NO308361B1 (no) 2000-09-04
RU2141965C1 (ru) 1999-11-27
ZA952059B (en) 1996-03-13
LV11182A (lv) 1996-04-20
US5656607A (en) 1997-08-12
EP0676409A1 (fr) 1995-10-11
UA44705C2 (uk) 2002-03-15
SA97170757A (ar) 2005-12-03
ES2189820T3 (es) 2003-07-16
FI111264B (fi) 2003-06-30
OA10200A (fr) 1996-12-18
ATE234853T1 (de) 2003-04-15
CA2164638A1 (fr) 1995-10-19
GB2288174A (en) 1995-10-11
GB9506856D0 (en) 1995-05-24
DE69529934T2 (de) 2003-09-04
EE04498B1 (et) 2005-06-15
FI955913A0 (fi) 1995-12-08
HRP950217B1 (en) 2004-06-30
IL112954A0 (en) 1995-06-29
BG100150A (bg) 1996-06-28
TW316908B (no) 1997-10-01
HU215396B (hu) 1998-12-28
HRP950217A2 (en) 1997-08-31
YU49221B (sh) 2004-11-25
CZ322395A3 (en) 1996-08-14
CO4370097A1 (es) 1996-10-07
WO1995027720A1 (fr) 1995-10-19
FR2718450A1 (fr) 1995-10-13
MD663G2 (ro) 1997-07-31
JP3000023B2 (ja) 2000-01-17
PE2896A1 (es) 1996-02-12
AU684939B2 (en) 1998-01-08
SV1995000018A (es) 1997-10-24
AP587A (en) 1997-04-29
DZ1869A1 (fr) 2002-02-17
NZ284498A (en) 1997-07-27
CA2164638C (fr) 2003-12-30
PL180837B1 (pl) 2001-04-30
CN1059445C (zh) 2000-12-13
DK0676409T3 (da) 2003-06-23
NO954942D0 (no) 1995-12-06
LV11182B (en) 1997-04-20
DE69529934D1 (de) 2003-04-24
RO115634B1 (ro) 2000-04-28
EE9500080A (et) 1996-12-16
PT676409E (pt) 2003-08-29
IS1865B (is) 2003-05-02
MD663F1 (ro) 1997-01-31
BG61916B1 (bg) 1998-09-30
GEP19991836B (en) 1999-11-05
MY114672A (en) 2002-12-31
SK154695A3 (en) 1996-10-02
IL112954A (en) 2000-07-16
KR100317148B1 (ko) 2002-06-22
TNSN95026A1 (fr) 1996-02-06
AP9500743A0 (en) 1995-07-31
FR2718450B1 (fr) 1997-01-10
BR9506147A (pt) 1996-04-16
SI0676409T1 (en) 2003-06-30
CZ296005B6 (cs) 2005-12-14
US5760233A (en) 1998-06-02
EP0676409B1 (fr) 2003-03-19
JO1850B1 (en) 1995-12-27
JPH07278177A (ja) 1995-10-24
AU2310795A (en) 1995-10-30
FI955913A7 (fi) 1995-12-08
HU9503505D0 (en) 1996-02-28
SK284079B6 (sk) 2004-09-08
MA23501A1 (fr) 1995-12-31

Similar Documents

Publication Publication Date Title
NO954942D0 (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og anvendelse av derivatene som legemidler
NO964654L (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
NO993003D0 (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
NO20024176L (no) Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling
DK0885234T3 (da) Nye erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO991815L (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
NO20000294L (no) Derivater av acylpiperazinylpyrimidiner, deres fremstilling og anvendelse som legemidler
NO20012272D0 (no) Nye erythromycinderivater, fremstillingsmetode og anvendelse som medisiner
NO952677D0 (no) Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater
DK1004592T3 (da) Nye erythromycinderivater, deres fremstilling og deres anvendelse som medikamenter
DK1015421T3 (da) Nye phenylamidinderivater, fremgangsmåder til deres fremstilling og deres anvendelse som lægemidler
NO20003661D0 (no) Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme
NO983860D0 (no) Nye triazolopuriner, fremgangsmÕte for fremstilling av dem og deres anvendelse som legemidler
NO960272L (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
FI941094L (fi) Uudet erytromysiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
NO990302L (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av slike, samt deres anvendelse som medikamenter
NO992859D0 (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse og deres anvendelse som medikamenter
NO921908D0 (no) Aminosyreazetidinylsubstituerte pyridonderivater, deres fremstilling og anvendelse som medikamenter
DK0763535T3 (da) Piperidinylmethyloxazolidin-2-on-derivater, deres fremstilling og deres anvendelse som centralnervesystem-aktive forbindelser
DK0946580T3 (da) Nye erythromycinforbindelser, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO963129L (no) Nye leukotrien-B4-derivater, fremgangsmåte for fremstilling derav og anvendelse derav som legemidler
NO894516L (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
NO901892D0 (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
NO900119L (no) Fremgangsmaate for fremstilling av 7-aryl- og heteroaryletere av desacetylforskolin, og deres anvendelse som medikamenter.
NO904981D0 (no) Nye leukotrien-b4-derivater, fremgangsmaate for fremstilling av dem og deres anvendelse som legemidler.

Legal Events

Date Code Title Description
MK1K Patent expired